School of Medicine
Showing 51-100 of 271 Results
-
Jamie Zeitzer
Professor (Research) of Psychiatry and Behavioral Sciences (Sleep Medicine)
Current Research and Scholarly InterestsDr. Zeitzer is a circadian physiologist specializing in the understanding of the impact of light on circadian rhythms and other aspects of non-image forming light perception.
He examines the manner in which humans respond to light and ways to manipulate this responsiveness, with direct application to jet lag, shift work, and altered sleep timing in teens. Dr. Zeitzer has also pioneered the use of actigraphy in the determination of epiphenomenal markers of psychiatric disorders. -
Yuyang Zeng
Postdoctoral Scholar, Ophthalmology
Current Research and Scholarly InterestsTransgenic therapy for glaucoma based on disease-responsive promoters/enhancers
-
Xianghao Zhan
Postdoctoral Scholar, Biomedical Informatics
BioXianghao Zhan earned his Ph.D. in Bioengineering from Stanford University in 2024, with a minor in Biomedical Data Science. He also completed dual M.S. degrees in Bioengineering (2021) and Statistics (2023) at Stanford, and holds undergraduate degrees in Control Science and Engineering and in English Literature from Zhejiang University’s Chu Kochen Honors College, where he graduated summa cum laude in 2019.
His research centers on understanding and modeling brain injury and neurodegeneration through data-driven approaches grounded in biomechanics, medical imaging, and clinical evidence. Under the mentorship of Prof. David B. Camarillo and Prof. Olivier Gevaert, his doctoral work advanced the computational modeling of traumatic brain injury, including the development of more accurate brain strain estimators, interpretable kinematic-to-strain models, and the first large-animal biomechanics-to-pathology correlation study.
Beyond traumatic brain injury, his research portfolio spans clinical data analysis for neurodegenerative diseases such as ALS, pathology-informed modeling of blood-brain barrier disruption, survival prediction using patient-derived motor neurons, and imaging-informed diagnosis in cancer. He has also contributed to clinical text mining and sensor-based health monitoring in contexts such as COVID-19 prognosis, surface electromyography, and artificial olfaction.
Xianghao has published 21 peer-reviewed papers as first or co-first author in journals including NPJ Digital Medicine, IEEE JBHI, and IEEE T-BME, with five additional first-author submissions under review. He has served as a reviewer for over 10 scientific journals, including Annals of Biomedical Engineering and Journal of Neurotrauma, and presented his work in 14 international conferences. He has co-written five research grants, contributing to over $400,000 in funding for brain injury studies.
His contributions have been recognized with several competitive honors, including the Siebel Scholars Class of 2024, the IET William James Award, the IET Postgraduate Research Award, the Stanford Interdisciplinary Graduate Fellowship, and trainee awards from AMIA and the American Society for Neurotrauma.
Outside of research, he is an avid volleyball and tennis player, having led teams to 16 intramural championships at Stanford. He values collaboration, leadership, and the joy of teamwork—on and off the court. -
An Ni Zhang
Postdoctoral Scholar, Stanford Cancer Institute
BioAnni obtained her Ph.D. in Dr. James Johnson and Dr. Janel Kopp's labs at the University of British Columbia. Her Ph.D. work showed that hyperinsulinemia contributes to pancreatic cancer development. Her work also showed that insulin directly acted via the insulin receptors in pancreatic acinar cells to increase digestive enzyme production, thereby generating an inflammatory condition that accelerates neoplastic transformation. She is now working at Diehn lab to investigate the mechanisms of KEAP1 mutation-induced immunotherapy resistance in lung cancer.
-
Bing Melody Zhang
Clinical Associate Professor, Pathology
Current Research and Scholarly InterestsMy main research interests lie in the following areas:
1) HLA testing for BMT/solid organ transplantation
2) NGS-based TCR/Ig clonality/MRD testing
3) HLA testing in cellular therapy and oncology
4) Genetic/genomic testing for malignant and non-malignant hematologic disorders
5) HLA-related disease association/drug hypersensitivity testing. -
Chongyang Zhang
Postdoctoral Scholar, Cardiology
BioDr. Zhang is a Postdoctoral Scholar at RabLab in the cardiopulmonary division. She has a PhD in Pharmacology from University of Rochester, NY. She has research in cardiovascular research and chronobiology published in high impact peer-reviewed journals. She is recipient of honors including predoctoral fellowship from AHA, Travel Grant for Early Career Investigators from Council on Arteriosclerosis, Thrombosis, and Vascular Biology. She has served as ad hoc reviewer for more than 40 manuscripts for reputed journals.
-
Fanglin Zhang, MD., PhD.
Clinical Associate Professor, Adult Neurology
BioDr. Zhang is a board-certified, fellowship-trained neurologist. She serves as a clinical assistant professor in the Department of Neurology at Stanford University School of Medicine.
Dr. Zhang diligently excels in diagnosing and treating complex neurological conditions. Her clinical interests span a broad spectrum, with a current emphasis on intractable epilepsy and urgent stroke care. With each patient, Dr. Zhang forms a strong alliance focused on overcoming neurological disease and improving quality of life. She practices a patient-centered and evidence-based medicine.
As a clinician educator, she finds joy in educating both patients and trainees. She also enjoys conducting cutting-edge clinical research. Her work has been published in numerous peer-reviewed journals, such as Neurological Sciences, Annals of Clinical and Translational Neurology, Neuroimage, Glia, Immunology, the Journal of Psychiatric Practice, Journal of Neuroimmunology, etc. Her current research interest includes clinical trials and a large cohort study of the impact of seizures on stroke outcomes.
Among her many honors, Dr. Zhang has won a grant award from the National Multiple Sclerosis Society. Dr. Zhang shows a great enthusiasm in public welfare. She has earned recognition for volunteering her time and expertise at family health centers, hospitals, and schools. -
Hao Zhang
Instructor, Cardiovascular Institute
BioI earned my M.D. from Peking Union Medical College, Tsinghua University. Subsequently, I completed my residency and served as a cardiac fellow at Fuwai Hospital, where I developed a strong foundation in the pathophysiology of cardiovascular diseases.
As a postdoctoral researcher and instructor in Dr. Joseph Wu’s lab at Stanford, I established a protocol to derive cardiac fibroblasts (CFs) from human iPSCs, providing an unlimited source of cells for studying cardiac fibrosis. This method generates homogenous iPSC-derived CFs that remain quiescent yet responsive to profibrotic stimuli. Notably, this protocol played a crucial role in developing a multiscale drug discovery platform that integrates human iPSCs, 3D-engineered heart tissues, and animal models of heart failure. Using this platform, I discovered novel signaling pathways and therapeutic targets for cardiac fibrosis. My most recent work has been published in Cell (https://doi.org/10.1016/j.cell.2024.09.034). -
Harrison G. Zhang
MD Student, expected graduation Spring 2028
MSTP Student
Grad Student, Institute for Human-Centered Artificial Intelligence (HAI)BioHarrison is an MD-PhD student at Stanford University advancing precision medicine and global health using machine learning and genomics. He studied statistics and biology at Columbia University, where he was elected to Phi Beta Kappa and awarded Magna Cum Laude with Highest Honors in Field for his academic achievements.
-
Huaiyu Zhang
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Zhang obtained her MS in Neuroscience from the University of Southern California and earned her PhD in Clinical Psychology from Emory University. She completed both her predoctoral internship and postdoctoral fellowship at Emory University School of Medicine. Prior to joining Stanford in 2023, Dr. Zhang supported survivors of interpersonal violence at the University of California San Francisco Trauma Recovery Center for over seven years. Dr. Zhang embraces an integrative, contextualized, evidence-informed, and strength-based approach to teaching, supervision, and clinical care. She provides services in English and Mandarin.
